Key result
Valvuloarterial impedance fails to predict long-term mortality or distinguish true severe aortic stenosis.
Why the study?
Valvuloarterial impedance (Zva) has been proposed for risk stratification in paradoxical low-gradient aortic stenosis, but its prognostic value in low-ejection fraction/low-gradient AS was uncertain.
Does valvuloarterial impedance (Zva) improve risk stratification for mortality in patients with low-ejection fraction, low-gradient aortic stenosis?
Cohort (n=184)
Yes
Does valvuloarterial impedance (Zva) improve risk stratification for mortality in patients with low-ejection fraction, low-gradient aortic stenosis?
Valvuloarterial impedance (Zva) does not accurately distinguish between true and pseudo-severe aortic stenosis and fails to predict operative or long-term mortality in patients with low-ejection fraction, low-gradient aortic stenosis.
Zva should not guide mortality risk stratification in low-EF, low-gradient AS; leaves open whether alternative parameters improve prognostication.
OBJECTIVES: In a multicentre series of patients with low-ejection fraction/low-gradient aortic stenosis (LEF/LGAS), we evaluated the prognostic impact of valvuloarterial impedance (Zva). BACKGROUND: Zva in AS, a measure of global afterload taking into account systemic arterial compliance, has been proposed for risk stratification in paradoxical LGAS. We hypothesized that Zva could help risk stratification in LEF/LGAS. METHODS AND RESULTS: We retrospectively calculated Zva (5.6 ± 1.7 mmHg/mL/m(2)) of 184 consecutive patients (mean age: 71 ± 10 years) with severe symptomatic LEF/LGAS (valve area ≤1 cm2;, EF ≤40%, mean transaortic pressure gradient ≤40 mmHg) included between 1995 and 2005 in a multicentre registry. Zva was higher in patients with LVEF at rest ≤20% (6.6 ± 2.3 vs. 5.5 ± 1.6; P = 0.05) and correlated negatively with LVEF at rest (R = -0.25; P = 0.001). Zva was lower in patients without contractile reserve (CR) on dobutamine stress echocardiography (DSE) compared with patients with true severe AS (5.3 ± 1.3 vs. 5.8 ± 1.8 mmHg/mL/m(2); P = 0.048). Zva and the variation in stroke volume during DSE were positively correlated (P = 0.0001) but Zva did not allow distinction between true and pseudo-severe AS (5.8 ± 1.8 vs. 5.3 ± 1.8 mm Hg/mL/m(2); P = 0.30). In the total population, Zva was not predictive of long-term mortality. In the 128 patients who underwent aortic valve replacement, Zva was not predictive of operative death and of long-term mortality. CONCLUSIONS: Increased Zva is related to low LVEF and more frequent CR on DSE in LEF/LGAS. However, Zva did not allow an accurate distinction between true and pseudo-severe AS and failed to predict operative and long-term mortality after aortic valve replacement, in LEF/LGAS.
No takes yet. Share an insight, caveat, or question.
Lévy et al. (2011) conducted a cohort in low-ejection fraction/low-gradient aortic stenosis (n=184). Valvuloarterial impedance (Zva) was evaluated on long-term mortality. Valvuloarterial impedance (Zva) failed to predict long-term mortality and did not distinguish between true and pseudo-severe aortic stenosis (5.8 vs. 5.3 mm Hg/mL/m2; P=0.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: